Delivery Order SPE2DB20D1100-SPE2DB25FD6Q7
- Not listed
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $7,794.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count unit). The contract utilizes firm fixed-price pricing with an ultimate completion date of July 29, 2025, and represents a non-competitive, non-set-aside award. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,512.00 delivery order on July 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price contract with a completion date of July 22, 2025, and represents a non-set-aside competitive award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $15,833.37. This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $8,004.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a pharmaceutical product for urological treatment. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,784.72 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,248.63 by the Defense Logistics Agency on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging). The contract employs firm fixed pricing and carries an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $8,276.16. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $83,835.22 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The product will be...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,600.27 delivery order contract is for Myrbetriq ER 50 mg tablets, a prescription medication. The contract has a firm fixed price and an ultimate completion date of November 30, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6Q7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,923.12 to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems. The company's comprehensive federal contract portfolio includes delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This Myrbetriq order represents a routine pharmaceutical supply delivery within the scope of the company's broader global pharmaceutical support vehicle with the DLA, which enables the company to supply medical commodities to support military healthcare programs worldwide and serves customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/28/25 |